RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 123 filers reported holding RELMADA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,722,321 | +15.7% | 574,107 | -5.1% | 0.00% | – |
Q2 2023 | $1,488,926 | -64.2% | 605,254 | -67.1% | 0.00% | – |
Q1 2023 | $4,154,822 | -36.1% | 1,838,417 | -1.3% | 0.00% | – |
Q4 2022 | $6,502,366 | -91.8% | 1,863,142 | -13.5% | 0.00% | -100.0% |
Q3 2022 | $79,717,000 | +95.0% | 2,153,328 | +0.0% | 0.00% | +200.0% |
Q2 2022 | $40,883,000 | -22.4% | 2,152,911 | +10.2% | 0.00% | 0.0% |
Q1 2022 | $52,707,000 | +68.9% | 1,952,808 | +41.0% | 0.00% | 0.0% |
Q4 2021 | $31,211,000 | -1.6% | 1,385,235 | +14.5% | 0.00% | 0.0% |
Q3 2021 | $31,721,000 | -32.6% | 1,210,241 | -17.7% | 0.00% | 0.0% |
Q2 2021 | $47,058,000 | -10.2% | 1,470,107 | -1.2% | 0.00% | -50.0% |
Q1 2021 | $52,398,000 | +9.4% | 1,488,175 | -0.3% | 0.00% | 0.0% |
Q4 2020 | $47,882,000 | +5.0% | 1,493,019 | +23.1% | 0.00% | 0.0% |
Q3 2020 | $45,622,000 | -16.2% | 1,212,701 | -0.3% | 0.00% | 0.0% |
Q2 2020 | $54,449,000 | +234.0% | 1,216,765 | +154.5% | 0.00% | +100.0% |
Q1 2020 | $16,304,000 | +192.1% | 478,013 | +234.0% | 0.00% | – |
Q4 2019 | $5,582,000 | – | 143,113 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
Savior LLC | 3,500 | $10,500 | 0.07% |
Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |